mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.04 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.04 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.04 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.05 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.05 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.06 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.06 |